‘This excellent, pacy thriller is set in the hundred-billion-dollar world...With the author a former banker himself, the thrilling plot is underpinned with masses of convincing detail’ Daily Mail
‘Bingham’s plot has echoes of Michael Crichton, but the style is distinctively his own and his characters more rounded and credible than average’ Mail on Sunday
In the bestselling tradition of Jeffrey Archer and Dick Francis comes a hot new commercial talent.
A young scientist, Cameron, has an idea which could revolutionise medicine. She believes that, once published, her findings will change the world.
A maverick financier, Bryn, sees the potential, but convinces her that truth alone is never what secures change: it’s money, nous and competitive savvy.
He persuades her to go into business with him. Their aim: to build a stockmarket company worth a hundred million pounds – big enough to survive assault; strong enough to market Cameron’s technology to the entire world.
Corinth, a corporation worth a hundred billion dollars, sees Cameron’s technology as a threat and aims to wipe out the fledgling enterprise.
The story becomes a race to the stockmarket – and a battle to survive.
"Sobre este título" puede pertenecer a otra edición de este libro.
Gastos de envío:
EUR 11,83
De Reino Unido a Estados Unidos de America
Descripción Paperback. Condición: Brand New. In Stock. Nº de ref. del artículo: __0006513557
Descripción Condición: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Nº de ref. del artículo: ria9780006513551_lsuk
Descripción Condición: New. In. Nº de ref. del artículo: ria9780006513551_new
Descripción PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000. Nº de ref. del artículo: VC-9780006513551
Descripción Condición: NEW. Nº de ref. del artículo: NW9780006513551